YBX1 and non-small cell lung carcinoma: Knockdown of HOXC8 reversed the promoting effects of HOXC-AS3 overexpression on NSCLC, indicating that YBX1/HOXC8 is a key downstream mechanism mediating the function of HOXC-AS3 in NSCLC.